Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade.
Wang G, Chow RD, Zhu L, Bai Z, Ye L, Zhang F, Renauer PA, Dong MB, Dai X, Zhang X, Du Y, Cheng Y, Niu L, Chu Z, Kim K, Liao C, Clark P, Errami Y, Chen S
Cancer Discov. 2020 Dec;10(12):1912-1933. doi: 10.1158/2159-8290.CD-19-1448. Epub 2020 Sep 4.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
192162pGW02 AAV-TBG-Cre-sgP53-sgRNAAAV-TBG-Cre-sgP53-sgRNA
192163pGW03 AAV-TBG-Cre-sgRNAAAV-TBG-Cre-sgRNA
192164AAV-TBG-Cre-sgKmt2dAAV-TBG-Cre-sgKmt2d
192165AAV-TBG-Cre-sgArid1aAAV-TBG-Cre-sgArid1a
192166Lenti-sgKmt2d-sg1Lenti-sgKmt2d-sg1
192167Lenti-sgKmt2d-sg3Lenti-sgKmt2d-sg3
192169Lenti-sgArid1a-sg3Lenti-sgArid1a-sg3

Antibodies from Article